Hemp based chewing gum for IBS being tested: 5 things to know

Kathleen Blanchard's picture
IBS cannabinoid chewing gum being tested

AXIM® Biotechnologies has begun Phase 2 clinical trials to find out if a hemp based chewing gum could help those suffering from IBS. Here are 5 things to know about the potential new treatment, should the trial be successful.

Advertisement

The development of the chewing gum, called CanChew is based on delivering cannabinoids that are a group of active substances found in marijuana.

Cannabidiol (CBD) is the non-psychoactive compound in marijuana that has been studied for its medicinal effect; one of which is quelling inflammation.

AXIM® Biotechnologies will study 40 patients with IBS who will be given either a 50 mg or placebo to see how well the time released, hemp oil based gum reduces symptoms of bloating, pain and other symptoms of IBS - up to 6 servings of gum per day.

Advertisement

See: IBS affects men differently than women

The company notes if trials are successful they would quickly move forward to get the gum to market.

Advantages of the gum that would be prescription based include:

  • It is not habit forming
  • Available in all 50 states
  • Tastes goods
  • Can be used by vegans; is kosher and gluten-free
  • Is time released to give a lasting effect

“IBS is a very common and often painful disorder which is still difficult to manage. People often experience sudden flare-ups and for many it has a negative impact on their quality of life. CBD has shown to have promising effects, but there has been a clear need for practical and effective formulations. Providing it via a chewing gum results in sustained release of the compound and better bio-availability,” said Renger Witkamp, Professor and Chair in Nutrition and Pharmacology of Wageningen University where the study is being conducted.

Advertisement